These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance. Yang L; Zhang Y; Tang Y; Wang Y; Jiang P; Liu F; Feng N Sci Rep; 2023 Apr; 13(1):5779. PubMed ID: 37031216 [TBL] [Abstract][Full Text] [Related]
25. DDR1 (Discoidin Domain Receptor-1)-RhoA (Ras Homolog Family Member A) Axis Senses Matrix Stiffness to Promote Vascular Calcification. Ngai D; Lino M; Rothenberg KE; Simmons CA; Fernandez-Gonzalez R; Bendeck MP Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1763-1776. PubMed ID: 32493168 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines. Azizi R; Salemi Z; Fallahian F; Aghaei M J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567 [TBL] [Abstract][Full Text] [Related]
27. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition. Miao L; Zhu S; Wang Y; Li Y; Ding J; Dai J; Cai H; Zhang D; Song Y Med Oncol; 2013; 30(3):626. PubMed ID: 23761027 [TBL] [Abstract][Full Text] [Related]
28. Discovery of Liu L; Zhao L; Yang L; Chai M; Liu Z; Ma N; Wang Y; Wu Q; Guo J; Zhou F; Huang W; Ren X; Wang J; Ding M; Wang Z; Ding K J Med Chem; 2024 May; 67(10):8043-8059. PubMed ID: 38730324 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis. Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027 [TBL] [Abstract][Full Text] [Related]
31. Discoidin domain receptor 1 as a promising biomarker for high-grade gliomas. Erdem D; Gunaldi M; Karaman I; Adilay U; Yılmaz İU; Eseoglu M; Avcıkurt A; Isıksacan N; Erdogan U; Gunaldi O J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147958 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1. Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668 [TBL] [Abstract][Full Text] [Related]
33. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression. Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276 [TBL] [Abstract][Full Text] [Related]
34. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection. Xu M; Cui C Med Sci Monit; 2021 Nov; 27():e933109. PubMed ID: 34815375 [TBL] [Abstract][Full Text] [Related]
35. Discoidin domain receptor 1-deletion ameliorates fibrosis and promotes adipose tissue beiging, brown fat activity, and increased metabolic rate in a mouse model of cardiometabolic disease. Lino M; Ngai D; Liu A; Mohabeer A; Harper C; Caruso LL; Schroer SA; Fu F; McKee T; Giacca A; Woo M; Bendeck MP Mol Metab; 2020 Sep; 39():101006. PubMed ID: 32360427 [TBL] [Abstract][Full Text] [Related]
36. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma. Tao Y; Wang R; Lai Q; Wu M; Wang Y; Jiang X; Zeng L; Zhou S; Li Z; Yang T; Yao Y; Wu Y; Yu L; Fu Y; Lai W; Peng Y; Lu Y; Zhang Z; Guo C; Zhang G; Gou L; Yang J Mol Oncol; 2019 Sep; 13(9):1855-1873. PubMed ID: 31116512 [TBL] [Abstract][Full Text] [Related]
37. A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance. Ambrogio C; Darbo E; Lee SW; Santamaría D Cell Adh Migr; 2018; 12(4):394-397. PubMed ID: 29505315 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis. Valencia K; Ormazábal C; Zandueta C; Luis-Ravelo D; Antón I; Pajares MJ; Agorreta J; Montuenga LM; Martínez-Canarias S; Leitinger B; Lecanda F Clin Cancer Res; 2012 Feb; 18(4):969-80. PubMed ID: 22223527 [TBL] [Abstract][Full Text] [Related]
39. Altered Expression of DDR1 in Clear Cell Renal Cell Carcinoma Correlates With miR-199a/b-5p and Patients' Outcome. Krazinski BE; Kiewisz J; Sliwinska-Jewsiewicka A; Kowalczyk AE; Grzegrzolka J; Godlewski J; Kwiatkowski P; Dziegiel P; Kmiec Z Cancer Genomics Proteomics; 2019; 16(3):179-193. PubMed ID: 31018949 [TBL] [Abstract][Full Text] [Related]
40. Coexpression of the discoidin domain receptor 1 gene with oligodendrocyte-related and schizophrenia risk genes in the developing and adult human brain. Muntané G; Chillida M; Aranda S; Navarro A; Vilella E Brain Behav; 2021 Aug; 11(8):e2309. PubMed ID: 34323026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]